Skip to Content

APO AB 300 (Abacavir sulfate 300 mg (base))

Pill imprint APO AB 300 has been identified as Abacavir sulfate 300 mg (base).

Abacavir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Abacavir sulfate 300 mg (base) APO AB 300
Abacavir sulfate 300 mg (base) APO AB 300
Discount Card Promo
Abacavir sulfate
APO AB 300
300 mg (base)
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Apotex Corp
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
polyethylene glycol 8000
ferric oxide yellow
croscarmellose sodium
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6523 Major Pharmaceuticals

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.